Data / Drug companies / Inspec Solutions LLC.
Inspec Solutions LLC.: 16 products in the FDA NDC directory, labeler code 72667
Inspec Solutions LLC. (labeler code 72667) lists 16 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 16 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 3, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 72667
- Products in commercial distribution
- 16
- Packages
- 17
- Finished drugs by generic name
- 9
- Prescription products
- 0
- Over the counter products
- 16
- Flagged as original packager
- 14 of 14 products that carry the flag
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- February 26, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 16 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 16 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Lidocaine | 3 | 216 |
| Avobenzone, homosalate, octisalate, octocrylene | 3 | 157 |
| Menthol | 3 | 263 |
| Benzocaine | 2 | 110 |
| Penylephrine hci, witch hazel, lidocaine hcl, | 1 | 1 |
| Witch hazel penylephrine lidocaine | 1 | 1 |
| Avobenzone, humosalate, octisalate, octocrylene | 1 | 2 |
| Homosalate 10.00% octocrylene 6.00% avobenzone 3.00% | 1 | 2 |
| Tolnaftate | 1 | 99 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Spray | 4 | 25% |
| Gel | 4 | 25% |
| Lotion | 4 | 25% |
| Ointment | 3 | 18.8% |
| Stick | 1 | 6.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Amide Local Anesthetic | 5 |
| Antiarrhythmic | 5 |
| alpha-1 Adrenergic Agonist | 2 |
| Standardized Chemical Allergen | 2 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Fungi Nail Toe and Foot | 72667-346 | Ointment | Over the counter monograph drugs | November 3, 2026 |
| MyDerm SPF 50 | 72667-289 | Lotion | Over the counter monograph drugs | December 1, 2025 |
| MyDerm MEDICAL NEW Soothing Hemorrhoidal | 72667-287 | Spray | Over the counter monograph drugs | December 1, 2025 |
| MyDerm | 72667-081 | Spray | Over the counter monograph drugs | November 4, 2024 |
| MyDerm Medical 5 Lidocaine Numbing Roll-On | 72667-285 | Stick | Over the counter monograph drugs | March 6, 2024 |
| MyDerm Pro Freeze Cooling Menthol Pain Relief Roll-On | 72667-073 | Gel | Over the counter monograph drugs | March 6, 2024 |
| Mango Bay SPF 30 Gallon | 72667-040 | Lotion | Over the counter monograph drugs | June 26, 2022 |
| Mango Bay SPF 30 | 72667-039 | Lotion | Over the counter monograph drugs | June 26, 2022 |
| Mango Bay SPF 50 | 72667-035 | Lotion | Over the counter monograph drugs | June 26, 2022 |
| Mango Bay SPF 50 Sport | 72667-037 | Spray | Over the counter monograph drugs | June 25, 2022 |
| MyDerm Cooling Menthol Pain Relief with 50 Percent More Menthol | 72667-021 | Gel | Over the counter monograph drugs | December 27, 2021 |
| MyDerm Cooling Menthol Pain Relief with 50 Percent More Menthol | 72667-020 | Spray | Over the counter monograph drugs | December 27, 2021 |
| MyDerm Bite and Sting | 72667-341 | Ointment | Over the counter monograph drugs | December 14, 2021 |
| MyDerm Bite Relief | 72667-019 | Ointment | Over the counter monograph drugs | December 14, 2021 |
| MyDerm Aloe and Lidocaine | 72667-283 | Gel | Over the counter monograph drugs | February 26, 2019 |
| MyDerm | 72667-008 | Gel | Over the counter monograph drugs | February 26, 2019 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.